Navigation Links
Vanda Pharmaceuticals Initiates Phase III Clinical Study Aimed at Resetting the Body Clock
Date:8/26/2010

ROCKVILLE, Md., Aug. 26 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA), today announced it has initiated a Phase III clinical trial to evaluate tasimelteon in patients with Non-24-Hour Sleep Wake Disorder (N24HSWD), a condition experienced primarily by totally blind individuals that results in abnormal night sleep patterns and chronic daytime sleepiness.  Tasimelteon binds to high affinity melatonin receptors located in the brain that are believed to regulate circadian rhythms, or sleep/wake cycles.

"Blind individuals with no light perception do not receive external light and darkness signals that synchronize our internal body clocks," commented Mihael H. Polymeropoulos, M.D. President and Chief Executive Officer of Vanda.  "As a result, these individuals can live lives in a constant state of circadian misalignment.  Tasimelteon has the potential to be the first in the class of circadian regulators, drugs that may offer clinical benefits to patients with aberrant timing of the sleep/wake cycle."

About Study VP-VEC-162-3201

Vanda Study 3201 is designed to investigate the efficacy and safety of 20 mg tasimelteon versus placebo in totally blind individuals with N24HSWD, with a target enrollment of 160 individuals. The study includes a 6-month treatment period and an optional open-label extension. The primary endpoint of the study is improvement in Total Sleep Time (TST) during the night.  The study will also measure parameters of daytime sleep and laboratory measures of the synchronization between the internal body clock and the 24-hour environmental light/dark cycle. Vanda expects to report top-line results for this trial in the fourth quarter of 2011.

For more information about the clinical study please visit:

http://www.vandapharma.com/tasi3201.html<
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Vanda Presents Phase III Iloperidone Efficacy Data
5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
6. Vanda Pharmaceuticals Provides Update on Iloperidone
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading health care ... new IT value-added reseller (VAR) national contracts that expand ... and services at lower costs. These include manufacturer product ... as initiative assistance and ongoing IT consulting support. ...
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
(Date:1/15/2014)... 15, 2014  Manufacturers, suppliers and distributors of innovative ... protect their most important business assets, intellectual property ... Because of the highly-competitive nature of ... of the most litigious industry sectors of cases ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2
... , LAKE FOREST, Ill., Dec. 16 Hospira, ... pharmaceutical and medication delivery company, today announced that it will ... 2009 results and projections for 2010 on Thursday, Feb. 4, ... release its fourth-quarter and full-year 2009 results earlier that morning, ...
... , GREEN BAY, Wis., Dec. ... with DolCas Biotech for the use of super ... multiple EuroPharma formulations. The exclusive distribution territory ... food store channel and professional channel, which includes ...
Cached Medicine Technology:EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3
(Date:4/17/2014)... Colic affects about one in five infants in the ... during the first several months after birth. Research into ... promise; however, the April 1, 2014 issue of the ... on a study, "Probiotics and Infant Colic," concluding that ... for infant colic did not reduce crying or ...
(Date:4/17/2014)... by researchers at UC Davis has shown that the ... in cell division, also boosts the mitochondrial activity to ... complex has been shown to perform both jobs. This ... to control cellular energy production, potentially advancing cancer care ... in the journal Developmental Cell . , "These ...
(Date:4/17/2014)... days to find a colored ribbon representing a disease. A ... what color ribbon does one think of with lung cancer?, ... many suffering from the disease, black may be the only ... of lung cancer patients, primarily smokers between the ages of ... the stigma often felt by these patients, the emotional toll ...
(Date:4/17/2014)... study has found that India,s shocking rates of suicide ... who are clinging to tiny smallholdings less than ... such as cotton and coffee, that are highly susceptible ... range of previous case studies that point to a ... the ,liberalisation, of the nation,s economy during the 90s. ...
(Date:4/17/2014)... the leading weapon against the deadly disease could be ... indicating it simply needs to be administered differently. , ... anti-malarial drug chloroquine in treating and preventing the mosquito-bourne ... a million people each year around the world. , ... chloroquine, but research carried out at the Australian National ...
Breaking Medicine News(10 mins):Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 3Health News:Scientists find new way to fight malaria drug resistance 2
... ... MomAtLast.com , ... March 31, 2010 -- Phenomenal moms-helping-moms-to-be website MomAtLast.com announces a “ share your journey ... great resource for women of all ages who are trying to become parents – ...
... , ... to Increase Local Enrollment of Medical Clinical Trials , ... (PRWEB) March 29, 2010 -- In a move ... patient care site Accumed Research Associates of Garden City, NY on long Island has ...
... To ... offering a free virtual conference with 17 different presenters over two days on Saturday April ... free. , ... March 31, 2010 -- In honor of Autism Awareness month, momsfightingautism.com is offering a free ...
... ... with an exciting multi-media event at the Hilton Americas in Houston, Texas on March ... ... of CieAura Transparent Holographic Chips™, successfully launched its direct sales company with an exciting ...
... ... an internationally recognized leader in literacy research, remediation, and professional development, will help ... beginning April 1st, 2010. , ... San Luis Obispo, CA (Vocus) -- Lindamood-Bell Learning ...
... patients walking back to health with shelter dogs , TUESDAY, ... getting a new "leash" on life as they gain strength ... innovative program, called Cardiac Friends, is a partnership between ProHealth ... County, in Wisconsin. , "It,s a great way to help ...
Cached Medicine News:Health News:Share the Story Of How You Became a 'Mom At Last' And Win $100 2Health News:Accumed Research Associates Launches Official Website 2Health News:Accumed Research Associates Launches Official Website 3Health News:First Ever Virtual Autism Conference Featuring Temple Grandin and 16 speakers to discuss: &#8220;Things To Know About Autism&#8221; April 10th-11th. 2Health News:First Ever Virtual Autism Conference Featuring Temple Grandin and 16 speakers to discuss: &#8220;Things To Know About Autism&#8221; April 10th-11th. 3Health News:CieAura Launches Successfully with Over 3000 Attendees 2Health News:CieAura Launches Successfully with Over 3000 Attendees 3Health News:Lindamood-Bell to Help Commemorate Autism Awareness Day 2Health News:Lindamood-Bell to Help Commemorate Autism Awareness Day 3Health News:Lindamood-Bell to Help Commemorate Autism Awareness Day 4Health News:Man's Best Friend Helps Mend Broken Hearts 2Health News:Man's Best Friend Helps Mend Broken Hearts 3
... in gloves, Polymed has become even better. Polymed® ... of regular Polymed with the exciting addition of ... of antioxidants, which are vital to healthy skin. ... powder-free to reduce the potential for latex sensitization. ...
... DRAPE. Soft translucent material ... Latex finger cot with ... base. Full-width 50mm adhesive ... with finger lift for ...
CYSTOSCOPY "T". DRAPE...
Urological Drape Aggressive adhesive with no residue Latex-free finger cot Strong, low-glare matte finish film Non-linting, tear resistant poly release liner...
Medicine Products: